New York, NY -- (SBWIRE) -- 09/20/2013 -- StockMarketIntel.com issues a special report on the following stocks: Allied Irish Banks PLC (ADR) (OTCMKTS:AIBYY), UNISOURCE CORP (OTCMKTS:USRC), Chromadex Corp (OTCMKTS:CDXC), Muenchener Rueckversicherungs-Ges.AG-ADR (OTCMKTS:MURGY)
Allied Irish Banks PLC (ADR) (OTCMKTS:AIBYY) recently declined -0.58% while trading on 22,513 shares, at the price of $119. The stock changed hands in a range of $1.19 to $1.20 up till now, bringing its market capitalization at about $62.19 billion. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.58 and was moved to the maximum level of $1.40. Allied Irish Banks, p.l.c., together with its subsidiaries, provides personal, business, corporate, institutional, and commercial banking services in the Republic of Ireland and internationally. The company?s Personal and Business Banking segment offers various banking products and services, including current accounts, savings accounts, pension plans, mortgages, loans, insurance, investment options, and online services, as well as wealth management, credit card, phone, and Internet banking services.
Has AIBYY Found The Bottom And Ready To Gain Momentum? Find Out Here
UNISOURCE CORP (OTCMKTS:USRC) recently added 1.45%, while trading on 143,358 shares, at the price of $0.420. The stock changed hands in a range of $0.35 to $0.43 up till now. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.04 and was moved to the maximum level of $1.84.
Will USRC Continue To Move Higher? Find Out Here
Chromadex Corp (OTCMKTS:CDXC) recently declined -3.61% and was moving within a range of $0.80-$0.81, its current trading price is $0.800. The stock is moving up till now with a total volume of 12,000 shares, versus an average volume of 200,394 shares. The share price hit its 52-week low of $0.50 and $1.04 was the best price. Chromadex Corporation is a provider of research and quality-control products and services to the natural products industry. The Company’s products are used by customers worldwide in the dietary supplement, food and beverage, cosmetic and pharmaceutical industries.
Why Should Investors Buy CDXC After the Recent Fall? Just Go Here and Find Out
Muenchener Rueckversicherungs-Ges.AG-ADR (OTCMKTS:MURGY) added 0.67% in its current trading activity, bringing its market capitalization around $34.86 billion. The share price, after opening at $19.65, hit a high of $19.65 and hovered above $19.54, while its recent trading price was $19.57. The total number of shares changed hands during the current session up till now was 1,649 shares, as compared to average trading volume of 53,673 shares. Muenchener Rueckversicherungs Gesellschaft AG in Muenchen is a Germany-based holding company engaged in reinsurance and insurance business fields. The Company diversifies its operations into reinsurance, primary insurance, Munich Health and Asset management.
Why Should Investors Buy MURGY After The Recent Gain? Just Go Here and Find Out
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)